*Applications will be reviewed on a rolling-basis, and this opportunity will remain open until filled.
A research opportunity is currently available in the Office of Vaccines Research and Review (OVRR) at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in Silver Spring, Maryland.
A training opportunity is available for studying of humoral immune responses following SARS CoV-2 (COVID-19), RSV or influenza infections and vaccination in humans as well as animal studies to evaluate antibody responses to infection (influenza, RSV) after vaccination The candidate will be trained in advanced techniques developed in the lab including: in vitro cell cultures( viral infections); virus neutralization assays, cytokine production; whole genome gene-fragment phage display libraries (GFPDL); Surface plasmon resonance (SPR); recombinant protein expression in bacterial and mammalian systems; small animal models (vaccination and infection).
Anticipated Appointment Start Date: April 1, 2023; start date is flexible
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA. OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.
FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such topics as the following:
- Non-employee nature of the ORISE appointment;
- Prohibition on ORISE Fellows performing inherently governmental functions;
- Obligation of ORISE Fellows to convey all necessary rights to the FDA regarding intellectual property conceived or first reduced to practice during their fellowship;
- The fact that research materials and laboratory notebooks are the property of the FDA;
- ORISE fellow’s obligation to protect and not to further disclose or use non-public information.
Qualifications:
The qualified candidate must have received or be currently pursuing a Ph.D., MS, MD in one of the relevant fields (Life Sciences). The degree must be received before the start of the appointment and within 3 years of the appointment start date.
Experience with molecular biology, viral techniques, cell cultures and small animals will be preferred.
To Apply:
https://www.zintellect.com/Opportunity/Details/FDA-CBER-2023-07
Similar Positions
-
Fda Post Doctoral Fellowship: Cell Manufacturing, Center for Biologics Evaluation and Research (CBER), United States, about 22 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is currently available at the Center for Biologics Evaluation and Research (CBER), in the Office ...
-
Fda Post Baccalaureate Research Opportunity In Microbial Pathogenesis, Center for Biologics Evaluation and Research (CBER), United States, about 22 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is currently available in the Office of Vaccine Research and Review (OVRR) at the Center for Biol...
-
Fda Cder Fellowship In The Intranasal Administration Of Monoclonal Antibodies And Other Biological Therapeutics, Center for Drug Evaluation and Research (CDER), United States, about 22 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: Office of Pharmaceutical Quality Research (OPQR), Office of Pharmaceutical Quality (OPQ) within the Food and Drug Admini...
-
Fda Fellowship In Novel Computer Vision Systems For Behavior & Health Detection In Animal Studies, Center for Biologics Evaluation and Research (CBER), United States, about 22 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is currently available at the Center for Biologics Evaluation and Research (CBER), in the Office ...
-
Fda Pharmacovigilance Fellowship: Characterization Of Newly Identified Safety Signals , Center for Drug Evaluation and Research (CDER), United States, about 22 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available within the Food and Drug Administration (FDA) in The Center for Drug Evaluation and ...
-
Fda Postdoctoral Glyco Technology Lab Fellowship, Center for Drug Evaluation and Research (CDER), United States, about 22 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available within the Food and Drug Administration (FDA) in The Center for Drug Evaluation and ...